|
|
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
Mauricette Michallet
,
Jean-Pierre Gangneux
,
Antoine Lafuma
,
Raoul Herbrecht
,
Patricia Ribaud
et al.
Journal articles
hal-00681020v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Thierry Facon
,
Gordon Cook
,
Saad Z Usmani
,
Cyrille Hulin
,
Shaji Kumar
et al.
Journal articles
hal-03513973v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache-Ottou
,
Chrystelle Vidal
,
Sabeha Biichlé
,
Florian Renosi
,
Eve Poret
et al.
Journal articles
hal-02442440v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier
,
Jean-Francois Hamel
,
Jacques Delaunay
,
Eric Delabesse
,
Pierre-Yves Dumas
et al.
Journal articles
hal-03604930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort
Aurore Perrot
,
Olivier Decaux
,
Bruno Royer
,
Denis Caillot
,
Karim Belhadj Merzoug
et al.
Conference papers
hal-04069412v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Salvage Therapy Post Pomalidomide-Based Regimen in Relapsed/Refractory Myeloma
Guillemette Fouquet
,
Lionel Karlin
,
Margaret Macro
,
Denis Caillot
,
Murielle Roussel
et al.
Blood, 2015, 126 (23), pp.1831
Journal articles
hal-01300804v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma
Guillemette Fouquet
,
Lionel Karlin
,
Margaret Macro
,
Denis Caillot
,
Murielle Roussel
et al.
Journal articles
hal-01728968v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Maroulio Pertesi
,
Maxime Vallée
,
Xiaomu Wei
,
Maria Revuelta
,
Perrine Galia
et al.
Journal articles
hal-02190723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study
Jean-Pierre Gangneux
,
Jean El Cheikh
,
Raoul Herbrecht
,
Ibrahim Yakoub-Agha
,
Jean-Baptiste Quiniou
et al.
Journal articles
hal-01879612v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma
Charlotte Fontan
,
Mourad Tiab
,
Pascal Godmer
,
Odile Luycx
,
Olivier Allangba
et al.
Journal articles
hal-01439375v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma
Stephanie Guidez
,
Guillemette Fouquet
,
Helene Demarquette
,
Morgane Nudel
,
Eileen Boyle
et al.
Blood, 2015, 126 (23), pp.5379
Journal articles
hal-01290429v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.
Xavier Leleu
,
Lionel Karlin
,
Margaret Macro
,
Cyrille Hulin
,
Laurent Garderet
et al.
Journal articles
hal-01141134v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03
Arthur Bobin
,
Jerome Lambert
,
Stéphanie Ragot
,
Aurore Perrot
,
Salomon Manier
et al.
Conference papers
hal-04069432v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Raoul Herbrecht
,
Denis Caillot
,
Catherine Cordonnier
,
Anne Auvrignon
,
Anne Thiébaut
et al.
Journal articles
hal-00874741v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Associated medical consumption and costs during invasive fungal infection in acute myeloblastic leukemia patients in France
Jean-Pierre Gangneux
,
Bertrand Dupont
,
Mauricette Michallet
,
R. Herbrecht
,
Patricia Ribaud
et al.
108th General Meeting of the American Society for Microbiology, 2008, Washington, United States
Conference papers
hal-00676853v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02
Xavier Leleu
,
Michel Attal
,
Bertrand Arnulf
,
Philippe Moreau
,
Catherine Traulle
et al.
Journal articles
hal-01064417v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study
Charles Dumontet
,
Delphine Demangel
,
Perrine Galia
,
Lionel Karlin
,
Laurent Roche
et al.
Journal articles
hal-03980698v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018)
Stéphane Bretagne
,
Karine Sitbon
,
Marie Desnos-Ollivier
,
Dea Garcia-Hermoso
,
Valérie Letscher-Bru
et al.
Journal articles
hal-03658122v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|